These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28971756)

  • 21. [Amyloid typing from formalin-fixed paraffin-embedded tissues using LMD-LC-MS/MS system].
    Tasaki M; Obayashi K; Ueda M; Ando Y
    Rinsho Byori; 2014 Mar; 62(3):291-6. PubMed ID: 24800507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Classification of amyloidosis].
    Misumi Y; Ando Y
    Brain Nerve; 2014 Jul; 66(7):731-7. PubMed ID: 24998818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomics with Mass Spectrometry Imaging: Beyond Amyloid Typing.
    Lavatelli F; Merlini G
    Proteomics; 2018 Apr; 18(7):e1700353. PubMed ID: 29389069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic amyloidosis.
    Wechalekar AD; Gillmore JD; Hawkins PN
    Lancet; 2016 Jun; 387(10038):2641-2654. PubMed ID: 26719234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Classification of Amyloidosis by Model-Assisted Mass Spectrometry-Based Proteomics.
    Palstrøm NB; Rojek AM; Møller HEH; Hansen CT; Matthiesen R; Rasmussen LM; Abildgaard N; Beck HC
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Classification of amyloidosis by laser micro-dissection and mass spectrometry based proteomic analysis].
    Shen K; Sun W; Sun J; Sun W; Zhong D; Cao X; Zhou D; Li J
    Zhonghua Xue Ye Xue Za Zhi; 2015 Feb; 36(2):99-102. PubMed ID: 25778882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyloid Typing by Mass Spectrometry in Clinical Practice: a Comprehensive Review of 16,175 Samples.
    Dasari S; Theis JD; Vrana JA; Rech KL; Dao LN; Howard MT; Dispenzieri A; Gertz MA; Hasadsri L; Highsmith WE; Kurtin PJ; McPhail ED
    Mayo Clin Proc; 2020 Sep; 95(9):1852-1864. PubMed ID: 32861330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New advances in the subtyping of systemic amyloidosis].
    Sun WY; Li J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):259-62. PubMed ID: 24598691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis.
    Sethi S; Vrana JA; Theis JD; Leung N; Sethi A; Nasr SH; Fervenza FC; Cornell LD; Fidler ME; Dogan A
    Kidney Int; 2012 Jul; 82(2):226-34. PubMed ID: 22495291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Twists and turns of determining amyloid type and amyloid-related organ damage: discordance and clinical skepticism in the era of proteomic typing.
    Kaul E; Pilichowska M; Vullaganti M; Madan N; Comenzo RL
    Amyloid; 2014 Mar; 21(1):62-5. PubMed ID: 24256111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging mass spectrometry analysis of renal amyloidosis biopsies reveals protein co-localization with amyloid deposits.
    Casadonte R; Kriegsmann M; Deininger SO; Amann K; Paape R; Belau E; Suckau D; Fuchser J; Beckmann J; Becker M; Kriegsmann J
    Anal Bioanal Chem; 2015 Jul; 407(18):5323-31. PubMed ID: 25935672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amyloidosis of the Lung.
    Khoor A; Colby TV
    Arch Pathol Lab Med; 2017 Feb; 141(2):247-254. PubMed ID: 28134587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How to diagnose amyloidosis.
    Mollee P; Renaut P; Gottlieb D; Goodman H
    Intern Med J; 2014 Jan; 44(1):7-17. PubMed ID: 24024789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
    Chiasserini D; van Weering JR; Piersma SR; Pham TV; Malekzadeh A; Teunissen CE; de Wit H; Jiménez CR
    J Proteomics; 2014 Jun; 106():191-204. PubMed ID: 24769233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical markers in early diagnosis and management of systemic amyloidoses.
    Lavatelli F; Albertini R; Di Fonzo A; Palladini G; Merlini G
    Clin Chem Lab Med; 2014 Nov; 52(11):1517-31. PubMed ID: 24870609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Proteomics, a new tool for an accurate typing of amyloidosis].
    Colombat M; Holifanjaniaina S; Onifarasoaniaina S; Valleix S; Maisonneuve H; Kahn JE;
    Rev Med Interne; 2015 May; 36(5):346-51. PubMed ID: 25544147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal Amyloidosis.
    Mohamed N; Nasr SH
    Surg Pathol Clin; 2014 Sep; 7(3):409-25. PubMed ID: 26837447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomics and mass spectrometry in the diagnosis of renal amyloidosis.
    Picken MM
    Clin Kidney J; 2015 Dec; 8(6):665-72. PubMed ID: 26613021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Shotgun protein profile of human adipose tissue and its changes in relation to systemic amyloidoses.
    Brambilla F; Lavatelli F; Di Silvestre D; Valentini V; Palladini G; Merlini G; Mauri P
    J Proteome Res; 2013 Dec; 12(12):5642-55. PubMed ID: 24083510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum Proteomic Variability Associated with Clinical Phenotype in Familial Transthyretin Amyloidosis (ATTRm).
    Chan GG; Koch CM; Connors LH
    J Proteome Res; 2017 Nov; 16(11):4104-4112. PubMed ID: 28922609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.